Beck 2021.
Study characteristics | |||
Patient Sampling | Single‐group study estimating sensitivity and specificity: all patients with signs and symptoms of COVID‐19 presenting to an urgent care centre (n = 347) Recruitment: consecutive ("all patients") Prospective or retrospective: not stated; appears prospective Sample size (cases): 347 (61) |
||
Patient characteristics and setting | Setting: urgent care centre Location: Advocate Aurora Health Urgent Care Center, West Bend, WI Country: USA Dates: not stated Symptoms and severity: all symptomatic; no further details Demographics: age range 1‐90 years; ≤ 18 years 35.4%, 19‐50 years 38.3%, > 50 years 26.2% of participants Exposure history: not reported |
||
Index tests | Test name: SOFIA SARS Antigen FIA Manufacturer: Quidel Antibody: SARS‐CoV Ag target: not reported Test method: FIA Samples used: nasal; collection not described but appears to be HCW ("providers" mentioned in acknowledgements). IFU describes NMT samples Transport media: none; "swabs were carefully returned to the paper envelope in which they came and were placed in a sealed plastic specimen transport bag" Sample storage: none; "specimens were delivered to the laboratory (located within the same building) within 10 minutes of collection" Test operator: lab staff Definition of test positivity: not stated; "tested … according to the manufacturer’s package insert" Blinding reported: yes; done first and in separate lab Timing of samples: ≤ 5 days pso 298, 86.1%; > 5 days pso 48, 13.9% |
||
Target condition and reference standard(s) | Reference standard: transcription‐mediated amplification (TMA); Hologic Aptima Panther SARS‐CoV‐2 TMA test.
Cepheid Xpert Xpress SARS‐CoV‐2 RT‐PCR used for discrepant samples (after approx. 3 weeks' frozen storage) Definition of non‐COVID cases: as for cases Genetic target(s): not stated Samples used: NP in Amies bacterial transport medium (Copan, Brescia, Italy) Timing of reference standard: as for index test Blinded to index test: not stated; specimens were refrigerated and sent via courier to the central laboratory of ACL Laboratories Incorporated index test: no |
||
Flow and timing | Time interval between index and reference tests: simultaneous; paired swabs, NP collected first All participants received same reference standard: yes Missing data: 1 sample only (low risk) Uninterpretable results: 1 sample invalid on SOFIA Indeterminate results (index test): none reported Indeterminate results (reference standard): none reported. Discrepant analysis: 2/14 FNs were negative on Xpert Xpress; 1/1 FPs also negative Xpert Xpress Unit of analysis: participant |
||
Comparative | |||
Notes | Funding: none reported Publication status: published Source: Journal of Clinical Microbiology Author COI: none reported |
||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Yes | ||
Was a case‐control design avoided? | Yes | ||
Did the study avoid inappropriate inclusions? | Yes | ||
Could the selection of patients have introduced bias? | Low risk | ||
Are there concerns that the included patients and setting do not match the review question? | Low concern | ||
DOMAIN 2: Index Test (Evaluations of single test application) | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Yes | ||
If a threshold was used, was it pre‐specified? | Yes | ||
Could the conduct or interpretation of the index test have introduced bias? | Low risk | ||
Are there concerns that the index test, its conduct, or interpretation differ from the review question? | Low concern | ||
DOMAIN 2: Index Test (Evaluations of serial (repeat) testing) | |||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | No | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Unclear | ||
Reference standard does not incorporate result of index test? | Yes | ||
Could the reference standard, its conduct, or its interpretation have introduced bias? | High risk | ||
Are there concerns that the target condition as defined by the reference standard does not match the question? | High | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Yes | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | No | ||
Did all participants receive a reference standard? | Yes | ||
Could the patient flow have introduced bias? | Low risk |